Sökning: id:"swepub:oai:DiVA.org:uu-101979" >
The type I TGF-beta...
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
-
- Sorrentino, Alessandro (författare)
- Uppsala universitet,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- Thakur, Noopur (författare)
- Uppsala universitet,Institutionen för genetik och patologi,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- Grimsby, Susanne (författare)
- Uppsala universitet,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
visa fler...
-
- Marcusson, Anders (författare)
- Uppsala universitet,Institutionen för genetik och patologi,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- von Bulow, Verena (författare)
- Uppsala universitet,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- Schuster, Norbert (författare)
- Uppsala universitet,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- Zhang, Shouting (författare)
- Uppsala universitet,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- Heldin, Carl-Henrik, 1952- (författare)
- Uppsala universitet,Ludwiginstitutet för cancerforskning,1.Ludwig Institute for Cancer Research, Rudbeck Laboratory, Uppsala University, Sweden
-
- Landström, Maréne (författare)
- Umeå universitet,Uppsala universitet,Ludwiginstitutet för cancerforskning,Institutionen för genetik och patologi,Patologi
-
visa färre...
-
(creator_code:org_t)
- 2008-08-31
- 2008
- Engelska.
-
Ingår i: Nature Cell Biology. - : Springer Science and Business Media LLC. - 1465-7392 .- 1476-4679. ; 10:10, s. 1199-1207
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Transforming growth factor-β (TGF-β) is a multifunctional cytokine that regulates embryonic development and tissue homeostasis; however, aberrations of its activity occur in cancer. TGF-β signals through its Type II and Type I receptors (TβRII and TβRI) causing phosphorylation of Smad proteins. TGF-β-associated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, was originally identified as an effector of TGF-β-induced p38 activation. However, the molecular mechanisms for its activation are unknown. Here we report that the ubiquitin ligase (E3) TRAF6 interacts with a consensus motif present in TβRI. The TβRI–TRAF6 interaction is required for TGF-β-induced autoubiquitylation of TRAF6 and subsequent activation of the TAK1–p38/JNK pathway, which leads to apoptosis. TβRI kinase activity is required for activation of the canonical Smad pathway, whereas E3 activity of TRAF6 regulates the activation of TAK1 in a receptor kinase-independent manner. Intriguingly, TGF-β-induced TRAF6-mediated Lys 63-linked polyubiquitylation of TAK1 Lys 34 correlates with TAK1 activation. Our data show that TGF-β specifically activates TAK1 through interaction of TβRI with TRAF6, whereas activation of Smad2 is not dependent on TRAF6.
Nyckelord
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas